Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Academic Drug Discovery 2015

Academic Drug Discovery 2015

Date: Tuesday, 19 May 2015 - Wednesday, 20 May 2015
Location: Cambridge

Keynote Speakers

Stephen Frye

Stephen Frye
Director of The Center for Integrative Chemical Biology and Drug Discovery, University of North Carolina

Sir Tom Blundell

Sir Tom Blundell
Professor, University of Cambridge


SELECTBIO have been given the great honour of hosting a workshop on Academic Drug Discovery from Tuesday 19th – Wednesday 20th May 2015 at Buckingham House, Murray Edwards College, Cambridge University, UK. 

Applying ever changing models of partnership and technology transfer can be the most demanding of challenges facing any drug discovery project. The needs and requirements for each organisation involved can be so diverse, even when ultimately their goals are so similar. Bridging the gap between basic research and commercial application requires all parties to remain focused. With ever changing demands on global healthcare, pharmaceutical companies have been devolving their research activities to second and even third parties, thus diluting the high risk environment of drug discovery. This has created a great opportunity for academic and non governmental organisations to transform their intellectual property into practical interventions that will more swiftly be of benefit in front line medicine. 

This event will be the first of it’s kind in Europe, building on the success of our academic discovery events in the US and providing a platform for partnering in a global hub for life sciences research. It will attract participants who are currently open to partnering with academia, as well as those who are seeking to showcase their technical assets and expertise. There will be talks from industry service providers and stakeholders, universities and medical researchers, and pharmaceutical and biotechnology organisations from around the world. Looking forward to an era of drug discovery where cooperation and inter-organisational understanding enable revolutionary therapeutic innovation.

Agenda Topics

  • Drug discovery technology transfer
  • European lead generation and enabling open innovation
  • Novel approaches across different therapeutic areas
  • Partnering models for academia and industry
  • Professional translational research

Sponsorship and Exhibition Opportunities

Exhibition Team,
+44 (0) 1206 501654

Confirmed Speakers to date

Julian Blagg, Deputy Director, Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research
Patrick Chaltin, Director, K U Leuven Research & Development
Kurt Deshayes, Senior Scientist, Early Discovery Biochemistry, Genentech
Tim Hammonds, Deputy Director Drug Discovery, Cancer Research Technology
Trevor Howe, Director, Johnson & Johnson
Phil Jones, Director, European Screening Centre Newhouse, University of Dundee
Mark Moloney, Professor of Chemistry, University of Oxford
Susanne Muller Knapp, Group Head Structural Genomics Consortium (SGC), University Of Oxford
Niclas Nilsson, Open Innovation Manager, LEO Pharma
Peter Nussbaumer, Managing Director, Lead Discovery Center GmbH
Garry Pairaudeau, Global Head of Research Outsourcing, AstraZeneca
John Spencer, Professor, University of Sussex

Exhibition Sponsors Media Sponsors Networking

Add to Calendar ▼2015-05-19 00:00:002015-05-20 00:00:00Europe/LondonAcademic Drug Discovery 2015Academic Drug Discovery 2015 in